Armephaco JSC

Armephaco JSC EBIT Margin

The EBIT Margin (Operating Margin) of Armephaco JSC (AMP.VN) as of Oct 19, 2026 is 1.56 %. In the previous year, EBIT Margin (Operating Margin) was 1.03 % — a change of 51.33% (higher).

EBIT Margin

1.56 %

YoY

51.33%

Last updated:

EBIT Margin (Operating Margin) of Armephaco JSC is 2025 1.56 % . EBIT Margin (Operating Margin) of Armephaco JSC was 2024 1.03 % . It decreases by 51.33% higher compared to the previous year.

For Armephaco JSC, the operating (EBIT) margin of 1.6% is broadly stable versus 1.5% a few years ago.

The Armephaco JSC EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
2.93 VND
Jan 1, 2019
2.92 VND
Jan 1, 2020
3.33 VND
Jan 1, 2021
1.54 VND
Jan 1, 2022
1.37 VND
Jan 1, 2023
1.36 VND
Jan 1, 2024
1.03 VND
Jan 1, 2025
1.56 VND
The Armephaco JSC EBIT Margin history
YEAREBIT MarginYoY
1.56 %+51.33%
1.03 %-24.01%
1.36 %-1.05%
1.37 %-10.72%
1.54 %-53.86%
3.33 %+13.91%
2.92 %-0.15%
2.93 %-21.28%
3.72 %+18.66%
3.13 %+23.02%
2.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

EBIT Margin (Operating Margin) of Armephaco JSC is 1.56 % in 2025.

EBIT Margin (Operating Margin) of Armephaco JSC changed from 1.03 % to 1.56 %, representing a 51.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Armephaco JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Armephaco JSC

All Key Metrics — Armephaco JSC